⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2226249 | 0.76 | — | — | |
| SCHEMBL7539944 | 0.72 | TSHR (0.36) | — | |
| SCHEMBL15972107 | 0.72 | TSHR (0.36) | — | |
| SCHEMBL2612612 | 0.71 | CYP2D6 (0.33) | — | |
| SCHEMBL15361 | 0.71 | — | — | |
| SCHEMBL10486974 | 0.69 | TSHR (0.33) | — | |
| SCHEMBL20957515 | 0.69 | — | — | |
| SCHEMBL3403436 | 0.69 | — | — | |
| Ethane SCHEMBL27264482 | 0.68 | — | — | |
| SCHEMBL27974496 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2760904-A1 | METHOD FOR PRODUCING A MOLDED FOAM ELEMENT | Eurofoam GmbH (AT) | 2014-08-06 | — | — | EP | disclosed |
| WO-2012135888-A1 | METHOD FOR PRODUCING A MOLDED FOAM ELEMENT | EUROFOAM GMBH (AT) | 2012-10-11 | — | — | WO | disclosed |
| EP-1463506-B1 | SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF AURORA KINASES | ASTRAZENECA AB (SE) | 2009-10-21 | — | — | EP | disclosed |
| US-20090215770-A1 | Substituted Quinazoline Derivatives as Inhibitors of Aurora Kinases | ASTRAZENECA AB (SE) | 2009-08-27 | — | — | US | disclosed |
| CN-100491372-C | Substituted quinazoline derivatives as inhibitors of aurora kinase | ASTRAZENECA AB (SE) | 2009-05-27 | — | — | CN | disclosed |
| US-7402585-B2 | Substituted quinazoline derivatives as inhibitors of aurora kinases | ASTRAZENECA AB (SE) | 2008-07-22 | — | — | US | disclosed |
| US-20050070561-A1 | Substituted quinazoline derivatives as inhibitors of aurora kinases | ASTRAZENECA AB (SE) | 2005-03-31 | — | — | US | disclosed |
| EP-1463506-A1 | SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF AURORA KINASES | Astrazeneca AB (SE) | 2004-10-06 | — | — | EP | disclosed |
| WO-2003055491-A1 | SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF AURORA KINASES | ASTRAZENECA AB (SE) | 2003-07-10 | — | — | WO | disclosed |